Last reviewed · How we verify
biologically active human fecal microbiota — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
biologically active human fecal microbiota (biologically active human fecal microbiota) — Virginia O. Shaffer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| biologically active human fecal microbiota TARGET | biologically active human fecal microbiota | Virginia O. Shaffer | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- biologically active human fecal microbiota CI watch — RSS
- biologically active human fecal microbiota CI watch — Atom
- biologically active human fecal microbiota CI watch — JSON
- biologically active human fecal microbiota alone — RSS
Cite this brief
Drug Landscape (2026). biologically active human fecal microbiota — Competitive Intelligence Brief. https://druglandscape.com/ci/biologically-active-human-fecal-microbiota. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab